![](/img/cover-not-exists.png)
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity
Saksø, Mette, Jensen, Kenneth, Andersen, Maria, Hansen, Christian Rønn, Eriksen, Jesper Grau, Overgaard, JensVolume:
148
Journal:
Radiotherapy and Oncology
DOI:
10.1016/j.radonc.2020.03.025
Date:
July, 2020
File:
PDF, 1.11 MB
2020